Pharmaron Beijing Co Ltd (3759)

Hong Kong
Currency in HKD
15.10
0.00(0.00%)
Delayed Data
3759 Scorecard
Full Analysis
Prominent player in the Life Sciences Tools & Services industry
Fair Value
Day's Range
15.0415.70
52 wk Range
7.9824.85
Key Statistics
Edit
Bid/Ask
15.22 / 15.22
Prev. Close
15.1
Open
15.62
Day's Range
15.04-15.7
52 wk Range
7.98-24.85
Volume
-
Average Volume (3m)
5.48M
1-Year Change
64.31%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3759 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
18.42
Upside
+21.97%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 6 consecutive years
Show more

Pharmaron Beijing Co Ltd Company Profile

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services. It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.

Employees
20295
Market
Hong Kong

Compare 3759 to Peers and Sector

Metrics to compare
3759
Peers
Sector
Relationship
P/E Ratio
22.5x31.8x−0.6x
PEG Ratio
1.09−0.790.00
Price/Book
3.2x2.5x2.6x
Price / LTM Sales
3.6x4.8x3.1x
Upside (Analyst Target)
19.6%15.4%52.8%
Fair Value Upside
Unlock17.3%8.4%Unlock

Analyst Ratings

13 Buy
1 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 18.42
(+21.97% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.06
Dividend Yield
1.46%
Industry Median 0.57%
Annualised payout
0.2199
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 29, 2024
EPS / Forecast
0.1903 / 0.2478
Revenue / Forecast
3.51B / 3.70B
EPS Revisions
Last 90 days

FAQ

What Is the Pharmaron Beijing Co Ltd (3759) Stock Price Today?

The Pharmaron Beijing Co Ltd stock price today is 15.10.

What Stock Exchange Does Pharmaron Beijing Co Ltd Trade On?

Pharmaron Beijing Co Ltd is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Pharmaron Beijing Co Ltd?

The stock symbol for Pharmaron Beijing Co Ltd is "3759."

Does Pharmaron Beijing Co Ltd Pay Dividends? What’s The Current Dividend Yield?

The Pharmaron Beijing Co Ltd dividend yield is 1.46%.

What Is the Pharmaron Beijing Co Ltd Market Cap?

As of today, Pharmaron Beijing Co Ltd market cap is 45.19B.

What is Pharmaron Beijing Co Ltd Earnings Per Share?

The Pharmaron Beijing Co Ltd EPS is 1.06.

What Is the Next Pharmaron Beijing Co Ltd Earnings Date?

Pharmaron Beijing Co Ltd will release its next earnings report on 30 Mar 2025.

From a Technical Analysis Perspective, Is 3759 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.